The era of prostate-specific membrane antigen (PSMA)-based theranostics for hepatocellular carcinoma is upcoming: are we ready for it?

Luca Filippi, Arthur J Braat, Orazio Schillaci

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)3977-3978
Number of pages2
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume49
Issue number12
DOIs
Publication statusPublished - Oct 2022

Keywords

  • Antigens, Surface
  • Carcinoma, Hepatocellular/diagnostic imaging
  • Glutamate Carboxypeptidase II
  • Humans
  • Liver Neoplasms/diagnostic imaging
  • Male
  • Precision Medicine
  • Prostate-Specific Antigen
  • Prostate/pathology
  • Prostatic Neoplasms/diagnostic imaging

Cite this